Fibrovein 0.5% Injection is a sclerosing medicine containing sodium tetradecyl sulfate, used by appropriately trained healthcare professionals for the treatment of suitable superficial veins.
Fibrovein works as a sclerosant, causing controlled irritation to the inside of the treated vein. This results in the vein closing and subsequently being reabsorbed by the body.
The 0.5% strength is formulated for appropriate indications and treatment protocols as specified in the product information.
Supplied as a pack of 5 x 2ml ampoules, Fibrovein 0.5% Injection is intended for professional clinical use and should only be administered by appropriately qualified healthcare professionals.0.5% Sodium Tetradecyl Sulfate
Fibrovein 0.5% contains sodium tetradecyl sulfate, an established sclerosant used in appropriate sclerotherapy procedures.
Sclerotherapy Treatment
The medicine is administered into suitable veins as part of a professional sclerotherapy procedure.
2ml Ampoules
Each ampoule contains 2ml of Fibrovein 0.5% Injection.
Pack of 5
Supplied as 5 x 2ml ampoules, providing a convenient pack size for professional clinical use.
Prescription Medicine
Fibrovein is a prescription-only medicine (POM) and should only be supplied and administered in accordance with the relevant prescribing requirements and product information.
Fibrovein provides an established pharmaceutical option for healthcare professionals performing appropriate sclerotherapy procedures.
The 0.5% formulation provides a specific sodium tetradecyl sulfate concentration intended for suitable superficial vein treatment, while the 2ml ampoule format allows controlled preparation according to the prescribed treatment protocol.
Key features include:
Fibrovein 0.5% Injection is used for appropriate sclerotherapy treatment of superficial veins, including certain:
The appropriate strength and treatment technique depend on the vein size, anatomical location, clinical indication and individual patient assessment.
Always consult the current Summary of Product Characteristics (SmPC) for the licensed indications and dosing information.
Fibrovein contains sodium tetradecyl sulfate, a sclerosant.
When injected into an appropriate vein, the active ingredient causes controlled damage to the vein’s inner lining. This triggers a local inflammatory response and subsequent fibrosis and closure of the treated vein.
Over time, the closed vein is naturally broken down and reabsorbed by the body.
The product must be administered using an appropriate sclerotherapy technique by a suitably trained healthcare professional.
